A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L. Hyer, Neil Bence, Robert Griffin et al.|Nature Medicine|2018Cited by 453
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Stephen Grossman et al.|Journal of Medicinal Chemistry|2021Cited by 205
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Pengfei Yu et al.|Science Translational Medicine|2021Cited by 139
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Ruth Adams et al.|Journal of Medicinal Chemistry|2011Cited by 33
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O. Duffey, Qin Zhang, Ruth Adams et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 15